ASML Holding NV (ASML) today announces 2008 third quarter results
according to US GAAP as follows:
-
Q3 2008 net sales of EUR 696 million versus Q2 2008 net sales of EUR
844 million (Q3 2007 net sales of EUR 934 million).
-
Q3 2008 net income of EUR 73 million or 10.5 percent of net sales
versus Q2 2008 net income of EUR 192 million or 22.7 percent of net
sales (Q3 2007 net income of EUR 166 million or 17.8 percent of net
sales).
-
Q3 2008 net bookings valued at EUR 498 million with 31 systems
including 18 new and 13 used systems, leading to an order backlog
valued at EUR 1,028 million as of September 28, 2008.
"Sales and profit in the third quarter were in
line with our guidance thanks to our leading position in immersion
lithography products where market demand has held up despite a weak
global economy and credit turmoil,” said Eric
Meurice, president and CEO of ASML. "Generating
75 percent of our net sales and 87 percent of our bookings in the
quarter, our immersion systems enable customers to aggressively reduce
their cost per function in a difficult semiconductor environment. Demand
for capacity expansion systems remained weak and as guided we lowered
our expenses significantly in response to a softening business
environment,” Meurice said.
Operations Update
In Q3 2008, ASML’s net sales of EUR 696
million included 26 new and 11 used systems, totaling net system sales
of EUR 591 million, and net service and field options sales of EUR 105
million. Net system sales for Q2 2008 included the shipment of 31 new
and 8 used machines, totaling EUR 726 million, and net service and field
options sales of EUR 118 million.
The Q3 2008 average selling price for a new system was stable at EUR
21.6 million, compared with the Q2 2008 average selling price for a new
system of EUR 21.7 million, reflecting the focus on our most advanced
technology. The Q3 2008 average selling price for all ASML systems sold
was EUR 16.0 million, compared with the Q2 2008 ASP of EUR 18.6 million,
as a result of a larger proportion of used systems.
Q3 2008 net bookings totaled 31 systems valued at EUR 498 million. The
orders contained 18 new systems with an average selling price for new
systems of EUR 22.1 million and 13 used systems with an average selling
price of EUR 7.7 million. We received bookings for 16 immersion systems,
four of which for used systems.
ASML’s order backlog as of September 28, 2008
was EUR 1,028 million, totaling 53 systems with an average selling price
of EUR 19.4 million. For comparison, ASML’s
backlog as of June 29, 2008 was valued at EUR 1,106 million, totaling 59
systems with an average selling price of EUR 18.8 million.
In Q3 2008, ASML generated a net income of EUR 73 million or EUR 0.17
per ordinary share as compared with a net income of EUR 192 million in
Q2 2008 or EUR 0.45 per ordinary share including non-recurring tax
income of approximately EUR 70 million.
The company’s Q3 2008 gross margin was 38.1
percent, compared with the Q2 2008 gross margin of 40.0 percent,
consistent with a lower level of net sales.
Q3 2008 research and development (R&D) costs were EUR 130 million net of
credits, stable compared with Q2 2008 R&D costs of EUR 130 million net
of credits.
Selling, general and administrative (SG&A) costs were EUR 52 million in
Q3 2008, compared with SG&A costs of EUR 56 million in Q2 2008.
Net cash from operations was EUR 21 million in Q3 2008, impacted by
push-outs of planned systems into 2009. ASML ended Q3 2008 with EUR
1,313 million in cash and cash equivalents.
Outlook
"The current economic turmoil and the
reassessment by some of our customers of their investments and strategic
alliances make it difficult for us to guide on short term bookings or
give a mid term sales forecast. However, we received orders for 16
immersion systems in the third quarter, which is a testimonial to the
strength of our advanced product portfolio. Even during this downturn,
continued immersion technology investments remain necessary for
technology transitions and we expect to see quarterly sales at levels
that should secure a positive operating profit margin. This will be
supported by our ability to further adjust costs with our outsourced
business flexibility model. ASML’s strong
financial position will allow for sustained strategic investments in
technology development and production facilities that will be required
for success when the industry recovers. Indeed, we will be shipping in
H1 2009 our latest TWINSCAN™ XT:1950i
immersion system which offers a 25 percent performance improvement
compared to our current leading architecture and takes single exposure
imaging down to 38 nanometers. In addition to investing in a new double
patterning lithography platform to address the 32 nanometer node and
beyond, we are making significant investments in Extreme Ultraviolet
(EUV) in order to lead the industry into the next generation technology.
We just unveiled a production system roadmap that supports
cost-effective chip manufacturing to 22 nanometers and beyond, and have
orders for five production systems with delivery starting in 2010,”
Meurice said.
In view of the wait-and-see attitude of the market, the company expects
to ship 26 systems in Q4 2008 with an average selling price of EUR 20.6
million for new systems and an average selling price for all systems of
EUR 16.5 million. As previously guided, ASML’s
2008 full year net sales will decline around 20 percent and the company
will thereby outperform peers. ASML expects a gross margin in Q4 2008 of
approximately 36 percent, R&D expenditures to be at EUR 124 million net
of credits and SG&A costs to decrease to EUR 47 million. We have used
and will use the flexibility in our organizational model to reduce costs
without forced redundancies.
About ASML
ASML is the world's leading provider of lithography systems for the
semiconductor industry, manufacturing complex machines that are critical
to the production of integrated circuits or chips. Headquartered in
Veldhoven, the Netherlands, ASML is traded on Euronext Amsterdam and
Nasdaq under the symbol ASML. ASML has more than 6,900 employees,
serving chip manufacturers in more than 60 locations in 16 countries.
For more information, visit our website: www.asml.com
IFRS Financial Reporting
ASML's primary accounting standard for quarterly earnings releases and
annual reports is US GAAP, the accounting standard generally accepted in
the United States. Quarterly US GAAP statements of
operations, statements of cash flows and balance sheets, and a
reconciliation of net income and equity from US GAAP to IFRS are
available on www.asml.com
In addition to reporting financial figures in accordance with US
GAAP, ASML also reports financial figures in accordance with IFRS for
statutory purposes. The most significant differences between US GAAP and
IFRS that affect ASML concern the capitalization of certain product
development costs, the accounting of stock option plans and the
accounting of income taxes. Quarterly IFRS statements of
operations, statements of cash flows, balance sheets and a
reconciliation of net income and equity from US GAAP to IFRS are
available on www.asml.com
The consolidated balance sheets of ASML Holding N.V. as of September 28,
2008, the related consolidated statements of operations and consolidated
statements of cash flows for the quarter ended September 28, 2008 as
presented in this press release are unaudited.
Investor and Media Call
A conference call for investors and media will be hosted by CEO Eric
Meurice and CFO Peter Wennink at 15:00 PM Central European Time / 09:00
AM Eastern U.S. time. Dial-in numbers are: in the Netherlands +31 20 531
5856 and the US +1 706 679 0473. To listen to the conference call,
access is also available via www.asml.com
A presentation about 2008 third quarter results is available on www.asml.com
A video statement of CFO Peter Wennink is available on www.asml.com
A replay of the Investor and Media Call will be available on www.asml.com
Forward Looking Statements
"Safe Harbor" Statement under the US Private Securities Litigation
Reform Act of 1995: the matters discussed in this document may include
forward-looking statements, including statements made about our outlook,
realization of backlog, IC unit demand, financial results, average sales
price, gross margin and expenses. These forward looking statements are
subject to risks and uncertainties including, but not limited to:
economic conditions, credit market deterioration on consumer confidence
which could affect our customers, product demand and semiconductor
equipment industry capacity, worldwide demand and manufacturing capacity
utilization for semiconductors (the principal product of our customer
base), competitive products and pricing, manufacturing efficiencies, new
product development and customer acceptance of new products, ability to
enforce patents and protect intellectual property rights, the outcome of
intellectual property litigation, availability of raw materials and
critical manufacturing equipment, trade environment, changes in exchange
rates and other risks indicated in the risk factors included in ASML’s
Annual Report on Form 20-F and other filings with the US Securities and
Exchange Commission.
|
ASML - Summary U.S. GAAP Consolidated Statements of Operations 1,4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended,
|
|
Nine months ended,
|
|
|
|
|
Sep 30,
2007
|
|
|
Sep 28,
2008
|
|
|
Sep 30,
2007
|
|
|
Sep 28,
2008
|
|
|
(in thousands EUR, except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net system sales
|
|
843,232
|
|
|
590,723
|
|
|
2,516,425
|
|
|
2,136,296
|
|
|
Net service and field option sales
|
|
91,142
|
|
|
105,770
|
|
|
296,842
|
|
|
323,562
|
|
|
Total net sales
|
|
934,374
|
|
|
696,493
|
|
|
2,813,267
|
|
|
2,459,858
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
549,411
|
|
|
431,062
|
|
|
1,653,220
|
|
|
1,483,334
|
|
|
Gross profit on sales
|
|
384,963
|
|
|
265,431
|
|
|
1,160,047
|
|
|
976,524
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development costs, net of credits
|
|
120,077
|
|
|
130,157
|
|
|
356,829
|
|
|
388,657
|
|
|
Amortization of in process R&D
|
|
-
|
|
|
-
|
|
|
23,148
|
|
|
-
|
|
|
Selling, general and administrative costs
|
|
56,045
|
|
|
51,933
|
|
|
168,771
|
|
|
165,628
|
|
|
Income from operations
|
|
208,841
|
|
|
83,341
|
|
|
611,299
|
|
|
422,239
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income
|
|
9,527
|
|
|
7,059
|
|
|
27,958
|
|
|
17,633
|
|
|
Income from operations before income taxes
|
|
218,368
|
|
|
90,400
|
|
|
639,257
|
|
|
439,872
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes
|
|
(52,089)
|
|
|
(17,106)
|
|
|
(160,797)
|
|
|
(29,478)
|
|
|
Net income
|
|
166,279
|
|
|
73,294
|
|
|
478,460
|
|
|
410,394
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net income per ordinary share
|
|
0.35
|
|
|
0.17
|
|
|
1.01
|
|
|
0.95
|
|
|
Diluted net income per ordinary share
|
|
0.35
|
2,3
|
|
0.17
|
3
|
|
1.00
|
2,3
|
|
0.94
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of ordinary shares used in computing per share amounts (in
thousands):
|
|
Basic
|
|
474,557
|
|
|
431,672
|
|
|
472,842
|
|
|
431,498
|
|
|
Diluted
|
|
481,724
|
2,3
|
|
434,491
|
3
|
|
479,881
|
2,3
|
|
434,859
|
3
|
|
ASML - Ratios and Other Data 1,4
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended,
|
|
Nine months ended,
|
|
|
Sep 30, 2007
|
|
Sep 28, 2008
|
|
Sep 30, 2007
|
|
Sep 28, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit as a % of net sales
|
41.2
|
|
38.1
|
|
41.2
|
|
39.7
|
|
Income from operations as a % of net sales
|
22.4
|
|
12.0
|
|
21.7
|
|
17.2
|
|
Net income as a % of net sales
|
17.8
|
|
10.5
|
|
17.0
|
|
16.7
|
|
Shareholders’ equity as a % of total
assets
|
35.7
|
|
50.3
|
|
35.7
|
|
50.3
|
|
Income taxes as a % of income before income taxes
|
23.9
|
|
18.9
|
|
25.2
|
|
6.7
|
|
Sales of systems total (in units)
|
59
|
|
37
|
|
205
|
|
126
|
|
ASP of systems sales (EUR million)
|
14.3
|
|
16.0
|
|
12.3
|
|
17.0
|
|
Value of backlog systems total (EUR million)
|
1,769
|
|
1,028
|
|
1,769
|
|
1,028
|
|
Backlog systems total (in units)
|
90
|
|
53
|
|
90
|
|
53
|
|
ASP of backlog systems (EUR million)
|
19.7
|
|
19.4
|
|
19.7
|
|
19.4
|
|
Value of bookings systems total (EUR million)
|
857
|
|
498
|
|
2,167
|
|
1,443
|
|
Net bookings total (in units)
|
40
|
|
31
|
|
132
|
|
90
|
|
ASP of bookings systems (EUR million)
|
21.4
|
|
16.1
|
|
16.4
|
|
16.0
|
|
Number of employees
|
6,403
|
|
6,907
|
|
6,403
|
|
6,907
|
|
ASML - Summary U.S. GAAP Consolidated Balance Sheets 1,4
|
|
|
|
|
|
|
|
|
|
Dec 31, 2007
|
|
Sep 28, 2008
|
|
(in thousands EUR)
|
|
|
|
|
|
|
|
|
|
|
|
ASSETS
|
|
|
|
|
|
Cash and cash equivalents
|
|
1,271,636
|
|
1,312,993
|
|
Accounts receivable, net
|
|
637,975
|
|
574,230
|
|
Inventories, net
|
|
1,102,210
|
|
1,134,039
|
|
Deferred tax assets short-term
|
|
73,019
|
|
82,767
|
|
Other current assets
|
|
234,529
|
|
261,341
|
|
Total current assets
|
|
3,319,369
|
|
3,365,370
|
|
|
|
|
|
|
|
Deferred tax assets long-term
|
|
141,032
|
|
139,351
|
|
Other assets
|
|
59,991
|
|
50,632
|
|
Goodwill
|
|
128,271
|
|
129,238
|
|
Other intangible assets, net
|
|
38,195
|
|
28,846
|
|
Property, plant and equipment, net
|
|
380,894
|
|
503,057
|
|
Total assets
|
|
4,067,752
|
|
4,216,494
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
|
|
Current liabilities
|
|
1,321,437
|
|
1,273,016
|
|
Deferred tax and other liabilities
|
|
245,415
|
|
215,182
|
|
Other deferred liabilities
|
|
7,936
|
|
8,749
|
|
Other long-term debt
|
|
602,016
|
|
596,699
|
|
Total liabilities
|
|
2,176,804
|
|
2,093,646
|
|
|
|
|
|
|
|
Shareholders’ equity
|
|
1,890,948
|
|
2,122,848
|
|
Total liabilities and shareholders’ equity
|
|
4,067,752
|
|
4,216,494
|
|
ASML - Summary U.S. GAAP Consolidated Statements of Cash Flows 1,4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended,
|
|
Nine months ended,
|
|
|
|
Sep 30, 2007
|
|
Sep 28, 2008
|
|
Sep 30, 2007
|
|
Sep 28, 2008
|
|
(in thousands EUR)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
Net income
|
|
166,279
|
|
|
73,294
|
|
|
478,460
|
|
|
410,394
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
28,008
|
|
|
29,177
|
|
|
105,527
|
|
|
86,298
|
|
|
Disposals of property, plant and equipment
|
|
1,698
|
|
|
1,413
|
|
|
12,572
|
|
|
3,828
|
|
|
Share-based payments
|
|
3,675
|
|
|
3,687
|
|
|
10,342
|
|
|
10,362
|
|
|
Change in tax assets and liabilities
|
|
(5,306
|
)
|
|
(5,970
|
)
|
|
24,274
|
|
|
(98,283
|
)
|
|
Change in assets and liabilities
|
|
(20,024
|
)
|
|
(80,747
|
)
|
|
(10,083
|
)
|
|
5,584
|
|
|
Net cash provided by operating activities
|
|
174,330
|
|
|
20,854
|
|
|
621,092
|
|
|
418,183
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
Purchases of property, plant and equipment
|
|
(49,676
|
)
|
|
(68,237
|
)
|
|
(125,188
|
)
|
|
(188,711
|
)
|
|
Proceeds from sale of property, plant and equipment
|
|
-
|
|
|
-
|
|
|
3,355
|
|
|
-
|
|
|
Purchases of intangible assets
|
|
-
|
|
|
(35
|
)
|
|
-
|
|
|
(35
|
)
|
|
Acquisition of subsidiary (net of cash acquired)
|
|
-
|
|
|
-
|
|
|
(188,011
|
)
|
|
-
|
|
|
Net cash used in investing activities
|
|
(49,676
|
)
|
|
(68,272
|
)
|
|
(309,844
|
)
|
|
(188,746
|
)
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
Purchase of shares in conjunction with conversion rights
|
|
|
|
|
|
|
|
|
|
of bond holders and stock options
|
|
-
|
|
|
-
|
|
|
(156,253
|
)
|
|
(87,603
|
)
|
|
Dividend paid
|
|
-
|
|
|
(394
|
)
|
|
-
|
|
|
(107,841
|
)
|
|
Net proceeds from issuance of shares and stock options
|
|
19,464
|
|
|
1,439
|
|
|
40,505
|
|
|
4,967
|
|
|
Net proceeds from issuance of bonds
|
|
-
|
|
|
-
|
|
|
593,790
|
|
|
-
|
|
|
Excess tax benefits from stock options
|
|
6,226
|
|
|
(1,943
|
)
|
|
7,062
|
|
|
4,027
|
|
|
Redemption and/or repayment of debt
|
|
(1,530
|
)
|
|
(1,280
|
)
|
|
(1,875
|
)
|
|
(1,280
|
)
|
|
Net cash provided by (used in) financing activities
|
|
24,160
|
|
|
(2,178
|
)
|
|
483,229
|
|
|
(187,730
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows
|
|
148,814
|
|
|
(49,596
|
)
|
|
794,477
|
|
|
41,707
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of changes in exchange rates on cash
|
|
(2,846
|
)
|
|
1,691
|
|
|
(5,107
|
)
|
|
(350
|
)
|
|
Net increase (decrease) in cash & cash equivalents
|
|
145,968
|
|
|
(47,905
|
)
|
|
789,370
|
|
|
41,357
|
|
|
ASML - Quarterly Summary U.S. GAAP Consolidated Statements of
Operations1,4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sep 30,
|
|
Dec 31,
|
|
Mar 30,
|
|
Jun 29,
|
|
Sep 28,
|
|
|
|
2007
|
|
|
2007
|
|
|
2008
|
|
|
2008
|
|
2008
|
|
|
(in millions EUR, except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net system sales
|
|
843.2
|
|
|
834.8
|
|
|
820.0
|
|
|
725.6
|
|
590.7
|
|
|
Net service and field option sales
|
|
91.2
|
|
|
120.1
|
|
|
99.2
|
|
|
118.6
|
|
105.8
|
|
|
Total net sales
|
|
934.4
|
|
|
954.9
|
|
|
919.2
|
|
|
844.2
|
|
696.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
549.4
|
|
|
565.3
|
|
|
545.6
|
|
|
506.7
|
|
431.1
|
|
|
Gross profit on sales
|
|
385.0
|
|
|
389.6
|
|
|
373.6
|
|
|
337.5
|
|
265.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development costs, net of credits
|
|
120.1
|
|
|
129.3
|
|
|
128.3
|
|
|
130.2
|
|
130.2
|
|
|
Selling, general and administrative costs
|
|
56.0
|
|
|
56.9
|
|
|
57.3
|
|
|
56.4
|
|
51.9
|
|
|
Income from operations
|
|
208.9
|
|
|
203.4
|
|
|
188.0
|
|
|
150.9
|
|
83.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income
|
|
9.5
|
|
|
5.5
|
|
|
4.2
|
|
|
6.4
|
|
7.1
|
|
|
Income from operations before income taxes
|
|
218.4
|
|
|
208.9
|
|
|
192.2
|
|
|
157.3
|
|
90.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefit from (provision for) income taxes
|
|
(52.1
|
)
|
|
(8.1
|
)
|
|
(47.1
|
)
|
|
34.7
|
|
(17.1
|
)
|
|
Net income
|
|
166.3
|
|
|
200.8
|
|
|
145.1
|
|
|
192.0
|
|
73.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net income per ordinary share
|
|
0.35
|
|
|
0.46
|
|
|
0.34
|
|
|
0.45
|
|
0.17
|
|
|
Diluted net income per ordinary share 2,3
|
|
0.35
|
|
|
0.45
|
|
|
0.33
|
|
|
0.44
|
|
0.17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of ordinary shares used in computing per share amounts (in
thousands):
|
|
Basic
|
|
474,557
|
|
|
439,317
|
|
|
431,600
|
|
|
431,221
|
|
431,672
|
|
|
Diluted 2,3
|
|
481,724
|
|
|
444,569
|
|
|
434,959
|
|
|
434,585
|
|
434,491
|
|
|
ASML - Quarterly Summary Ratios and other data 1,4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sep 30,
|
|
Dec 31,
|
|
Mar 30,
|
|
Jun 29,
|
|
Sep 28,
|
|
|
|
2007
|
|
2007
|
|
2008
|
|
2008
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit as a % of net sales
|
|
41.2
|
|
40.8
|
|
40.6
|
|
40.0
|
|
|
38.1
|
|
Income from operations as a % of net sales
|
|
22.4
|
|
21.3
|
|
20.5
|
|
17.9
|
|
|
12.0
|
|
Net income as a % of net sales
|
|
17.8
|
|
21.0
|
|
15.8
|
|
22.7
|
|
|
10.5
|
|
Shareholders' equity as a % of total assets
|
|
35.7
|
|
46.5
|
|
44.5
|
|
49.7
|
|
|
50.3
|
|
Income taxes as a % of income before income taxes
|
|
23.9
|
|
3.9
|
|
24.5
|
|
(22.1
|
)
|
|
18.9
|
|
Sales of systems total (in units)
|
|
59
|
|
55
|
|
50
|
|
39
|
|
|
37
|
|
ASP of system sales (EUR million)
|
|
14.3
|
|
15.2
|
|
16.4
|
|
18.6
|
|
|
16.0
|
|
Value of backlog systems total (EUR million)
|
|
1,769
|
|
1,697
|
|
1,167
|
|
1,106
|
|
|
1,028
|
|
Backlog systems total (in units)
|
|
90
|
|
89
|
|
65
|
|
59
|
|
|
53
|
|
ASP of backlog systems (EUR million)
|
|
19.7
|
|
19.1
|
|
18.0
|
|
18.8
|
|
|
19.4
|
|
Value of booking systems total (EUR million)
|
|
857
|
|
803
|
|
312
|
|
632
|
|
|
498
|
|
Net bookings total (in units)
|
|
40
|
|
54
|
|
26
|
|
33
|
|
|
31
|
|
ASP of bookings systems (EUR million)
|
|
21.4
|
|
14.9
|
|
12.0
|
|
19.2
|
|
|
16.1
|
|
Number of employees
|
|
6,403
|
|
6,582
|
|
6,765
|
|
6,821
|
|
|
6,907
|
|
ASML - Summary U.S. GAAP Consolidated Balance Sheets 1,4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sep 30,
|
|
Dec 31,
|
|
Mar 30,
|
|
Jun 29,
|
|
Sep 28,
|
|
|
|
2007
|
|
2007
|
|
2008
|
|
2008
|
|
2008
|
|
(in millions EUR)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
2,445.2
|
|
1,271.6
|
|
1,397.1
|
|
1,360.9
|
|
1,313.0
|
|
Accounts receivable, net
|
|
611.7
|
|
638.0
|
|
741.5
|
|
516.9
|
|
574.2
|
|
Inventories, net
|
|
1,021.2
|
|
1,102.2
|
|
1,152.0
|
|
1,130.2
|
|
1,134.0
|
|
Deferred tax assets short-term
|
|
131.3
|
|
73.0
|
|
71.1
|
|
69.8
|
|
82.8
|
|
Other current assets
|
|
214.2
|
|
234.6
|
|
267.6
|
|
262.2
|
|
261.4
|
|
Total current assets
|
|
4,423.6
|
|
3,319.4
|
|
3,629.3
|
|
3,340.0
|
|
3,365.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred tax assets long-term
|
|
143.5
|
|
141.0
|
|
135.8
|
|
157.7
|
|
139.4
|
|
Other assets
|
|
39.9
|
|
60.0
|
|
85.7
|
|
39.3
|
|
50.6
|
|
Goodwill
|
|
133.4
|
|
128.3
|
|
119.7
|
|
119.8
|
|
129.2
|
|
Other intangible assets, net
|
|
44.2
|
|
38.2
|
|
32.5
|
|
30.1
|
|
28.8
|
|
Property, plant and equipment, net
|
|
343.3
|
|
380.9
|
|
401.4
|
|
458.1
|
|
503.1
|
|
Total assets
|
|
5,127.9
|
|
4,067.8
|
|
4,404.4
|
|
4,145.0
|
|
4,216.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities
|
|
2,391.5
|
|
1,321.4
|
|
1,562.3
|
|
1,247.3
|
|
1,273.0
|
|
Deferred tax and other liabilities
|
|
248.3
|
|
245.4
|
|
261.5
|
|
227.0
|
|
215.2
|
|
Other deferred liabilities
|
|
8.2
|
|
8.0
|
|
7.1
|
|
18.5
|
|
8.8
|
|
Convertible subordinated debt
|
|
44.5
|
|
-
|
|
-
|
|
-
|
|
-
|
|
Other long-term debt
|
|
604.0
|
|
602.0
|
|
615.3
|
|
591.6
|
|
596.7
|
|
Total liabilities
|
|
3,296.5
|
|
2,176.8
|
|
2,446.2
|
|
2,084.4
|
|
2,093.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders’ equity
|
|
1,831.4
|
|
1,891.0
|
|
1,958.2
|
|
2,060.6
|
|
2,122.8
|
|
Total liabilities and shareholders’
equity
|
|
5,127.9
|
|
4,067.8
|
|
4,404.4
|
|
4,145.0
|
|
4,216.5
|
|
ASML - Summary U.S. GAAP Consolidated Statements of Cash Flows 1,4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sep 30,
|
|
Dec 31,
|
|
Mar 30,
|
|
Jun 29,
|
|
Sep 28,
|
|
|
|
2007
|
|
|
2007
|
|
|
2008
|
|
|
2008
|
|
|
2008
|
|
|
(in millions EUR)
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
166.3
|
|
|
200.8
|
|
|
145.1
|
|
|
192.0
|
|
|
73.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
28.0
|
|
|
29.8
|
|
|
30.6
|
|
|
26.5
|
|
|
29.2
|
|
|
Disposals of property, plant and equipment
|
|
1.7
|
|
|
1.6
|
|
|
1.1
|
|
|
1.3
|
|
|
1.4
|
|
|
Share-based payments
|
|
3.7
|
|
|
6.2
|
|
|
3.5
|
|
|
3.1
|
|
|
3.7
|
|
|
Change in tax assets and liabilities
|
|
(5.3
|
)
|
|
(0.6
|
)
|
|
21.8
|
|
|
(114.1
|
)
|
|
(6.0
|
)
|
|
Change in assets and liabilities
|
|
(20.1
|
)
|
|
(157.9
|
)
|
|
65.2
|
|
|
21.2
|
|
|
(80.7
|
)
|
|
Net cash provided by operating activities
|
|
174.3
|
|
|
79.9
|
|
|
267.3
|
|
|
130.0
|
|
|
20.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of property, plant and equipment
|
|
(49.7
|
)
|
|
(54.0
|
)
|
|
(55.0
|
)
|
|
(65.5
|
)
|
|
(68.3
|
)
|
|
Proceeds from sale of property, plant and equipment
|
|
-
|
|
|
1.7
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
Net cash used in investing activities
|
|
(49.7
|
)
|
|
(52.3
|
)
|
|
(55.0
|
)
|
|
(65.5
|
)
|
|
(68.3
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
Capital repayment
|
|
-
|
|
|
(1,011.9
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
Purchase of shares in conjunction with conversion rights of bond
holders and stock options
|
|
|
|
|
|
|
|
|
|
|
|
|
-
|
|
|
(203.6
|
)
|
|
(87.6
|
)
|
|
-
|
|
|
-
|
|
|
Dividend paid
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(107.4
|
)
|
|
(0.4
|
)
|
|
Net proceeds from issuance of shares and stock options
|
|
19.5
|
|
|
22.8
|
|
|
3.0
|
|
|
0.5
|
|
|
1.4
|
|
|
Excess tax benefits from stock options
|
|
6.2
|
|
|
1.9
|
|
|
-
|
|
|
6.0
|
|
|
(1.9
|
)
|
|
Redemption and/or repayment of debt
|
|
(1.5
|
)
|
|
(7.8
|
)
|
|
-
|
|
|
-
|
|
|
(1.3
|
)
|
|
Net cash provided by (used in) financing activities
|
|
24.2
|
|
|
(1,198.6
|
)
|
|
(84.6
|
)
|
|
(100.9
|
)
|
|
(2.2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows
|
|
148.8
|
|
|
(1,171.0
|
)
|
|
127.7
|
|
|
(36.4
|
)
|
|
(49.6
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of changes in exchange rates on cash
|
|
(2.8
|
)
|
|
(2.6
|
)
|
|
(2.2
|
)
|
|
0.2
|
|
|
1.7
|
|
|
Net increase (decrease) in cash & cash equivalents
|
|
146.0
|
|
|
(1,173.6
|
)
|
|
125.5
|
|
|
(36.2
|
)
|
|
(47.9
|
)
|
ASML - Notes to the Summary U.S. GAAP Consolidated Financial
Statements
Basis of Presentation
ASML follows accounting principles generally accepted in the United
States of America ("U.S. GAAP”).
Further disclosures, as required under U.S. GAAP in annual reports, are
not included in the summary consolidated financial statements. Unless
stated otherwise, the accompanying consolidated financial statements are
stated in thousands of euros (‘EUR’).
Principles of consolidation
The consolidated financial statements include the accounts of ASML
Holding N.V. and all of its majority-owned subsidiaries. Subsidiaries
are all entities over which ASML has the power to govern the financial
and operating policies generally accompanying a shareholding of more
than one half of the voting rights. All intercompany profits, balances
and transactions have been eliminated in the consolidation.
Use of estimates
The preparation of ASML’s consolidated
financial statements in conformity with U.S. GAAP requires management to
make estimates and assumptions that affect the reported amounts of
assets and liabilities and the disclosure of contingent assets and
liabilities on the balance sheet dates and the reported amounts of
revenue and expense during the reported periods. Actual results could
differ from those estimates.
Recognition of revenues
ASML recognizes revenue when all four revenue recognition criteria are
met: persuasive evidence of an arrangement exists; delivery has occurred
or services have been rendered; seller’s
price to the buyer is fixed or determinable; and collectibility is
reasonably assured. At ASML, this policy generally results in revenue
recognition from the sale of a system upon shipment. The revenue from
the installation of a system is generally recognized upon completion of
that installation at the customer site. Each system undergoes, prior to
shipment, a "Factory Acceptance Test" in ASML's clean room facilities,
effectively replicating the operating conditions that will be present on
the customer's site, in order to verify whether the system will meet its
standard specifications and any additional technical and performance
criteria agreed with the customer. A system is shipped, and revenue
recognized, only after all specifications are met and customer sign-off
is received or waived. Although each system's performance is re-tested
upon installation at the customer's site, ASML has never failed to
successfully complete installation of a system at a customer’s
premises.
For arrangements containing multiple elements, the revenue relating to
the undelivered elements is deferred at estimated fair value until
delivery of these elements. Revenue from installation services and
service contracts provided to our customers is initially deferred and is
recognized when the installation is completed and, in case of service
contracts, over the life of those contracts. Revenue from extended and
enhanced warranties is recognized in income on a straight-line basis
over the contract period. The costs of providing services under extended
and enhanced warranties are recognized when they occur.
|
ASML – Reconciliation U.S. GAAP –
IFRS 1,4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
Three months ended,
|
|
Nine months ended,
|
|
|
|
|
|
Sep 30, 2007
|
|
Sep 28, 2008
|
|
Sep 30, 2007
|
|
|
Sep 28, 2008
|
|
|
|
(in thousands EUR)
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income under U.S. GAAP
|
|
166,279
|
|
|
73,294
|
|
|
478,460
|
|
|
|
410,394
|
|
|
|
|
Share-based payments (see Note 1)
|
|
280
|
|
|
(2,492
|
)
|
|
293
|
|
|
|
(3,009
|
)
|
|
|
|
Capitalization of development costs (see Note 2)
|
|
9,594
|
|
|
14,867
|
|
|
29,575
|
|
|
|
55,197
|
|
|
|
|
Convertible subordinated notes (see Note 3)
|
|
(2,265
|
)
|
|
-
|
|
|
(6,661
|
)
|
|
|
-
|
|
|
|
|
Income taxes (see Note 4)
|
|
-
|
|
|
(3,119
|
)
|
|
(7,648
|
)
|
|
|
(3,081
|
)
|
|
|
|
Net income under IFRS
|
|
173,888
|
|
|
82,550
|
|
|
494,019
|
|
|
|
459,501
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders’ equity
|
|
Sep 30,
|
|
Dec 31,
|
|
Mar 30,
|
|
|
Jun 29,
|
|
Sep 28,
|
|
|
|
2007
|
|
|
2007
|
|
|
2008
|
|
|
|
2008
|
|
|
2008
|
|
|
(in thousands EUR)
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders’ equity under U.S. GAAP
|
|
1,831,438
|
|
|
1,890,948
|
|
|
1,958,159
|
|
|
|
2,060,575
|
|
|
2,122,848
|
|
|
Share-based payments (see Note 1)
|
|
7,126
|
|
|
787
|
|
|
(3,420
|
)
|
|
|
(3,266
|
)
|
|
(7,904
|
)
|
|
Capitalization of development costs (see Note 2)
|
|
120,344
|
|
|
138,424
|
|
|
157,900
|
|
|
|
176,818
|
|
|
193,780
|
|
|
Convertible subordinated notes (see Note 3)
|
|
2,894
|
|
|
-
|
|
|
-
|
|
|
|
-
|
|
|
-
|
|
|
Income taxes (see Note 4)
|
|
-
|
|
|
8,852
|
|
|
9,186
|
|
|
|
8,478
|
|
|
5,969
|
|
|
Shareholders’ equity under IFRS
|
|
1,961,802
|
|
|
2,039,011
|
|
|
2,121,825
|
|
|
|
2,242,605
|
|
|
2,314,693
|
|
Notes to the reconciliation from U.S. GAAP to IFRS
Note 1 Share-based Payments
Under IFRS, ASML applies IFRS 2, "Share-based
Payments” beginning from January 1, 2004. In
accordance with IFRS 2, ASML records as an expense the fair value of its
share-based payments with respect to stock options granted to its
employees after November 7, 2002.
Under U.S. GAAP, ASML applies SFAS No. 123(R) "Share-Based
Payment” which is a revision of SFAS No.123.
SFAS 123(R) requires companies to recognize the cost of employee
services received in exchange for awards of equity instruments based
upon the grant-date fair value of those instruments.
Note 2 Capitalization of development costs
Under IFRS, ASML applies IAS 38, "Intangible
Assets”. In accordance with IAS 38,
capitalized development expenditures are amortized over the expected
useful life of the related product generally ranging between 2 and 3
years. Amortization starts when the developed product is ready for
volume production.
Under U.S. GAAP, ASML applies SFAS No. 2, "Accounting
for Research and Development Costs”. In
accordance with SFAS No. 2, ASML charges costs relating to research and
development to operating expense as incurred.
Note 3 Convertible Subordinated Notes
Under IFRS, ASML applies IAS 32 "Financial
instruments: Disclosure and presentation”
and IAS 39 "Financial instruments:
Recognition and measurement” beginning from
January 1, 2005. In accordance with IAS 32 and IAS 39, ASML accounts
separately for the equity and liability component of its convertible
notes ("Split accounting”).
The equity component relates to the grant of a conversion option to
shares to the holder of the bond. Split accounting results in additional
interest charges.
Under U.S. GAAP, ASML accounts for its convertible bonds as a liability
at the principal amount outstanding. As of December 31, 2007 ASML has no
Convertible Subordinated Notes outstanding.
Note 4 Income taxes
Under IFRS, ASML applies IAS 12, "Income
Taxes” beginning from January 1, 2005. In
accordance with IAS 12, unrealized net income resulting from
intercompany transactions that is eliminated from the carrying amount of
assets on consolidation gives rise to a temporary difference for which
deferred taxes must be recognized on consolidation. The deferred taxes
are calculated based on the tax rate applicable in the purchaser’s
tax jurisdiction.
Under U.S. GAAP, the elimination of unrealized net income from
intercompany transactions that are eliminated from the carrying amount
of assets on consolidation, give rise to a temporary difference for
which prepaid taxes must be recognized on consolidation. Contrary to
IFRS, the prepaid taxes under U.S. GAAP are calculated based on the tax
rate applicable in the seller’s tax
jurisdiction.
"Safe Harbor" Statement under the US Private Securities Litigation
Reform Act of 1995: the matters discussed in this document may include
forward-looking statements, including statements made about our outlook,
realization of backlog, IC unit demand, financial results, average sales
price, gross margin and expenses. These forward looking statements are
subject to risks and uncertainties including, but not limited to:
economic conditions, credit market deterioration on consumer confidence
which could affect our customers, product demand and semiconductor
equipment industry capacity, worldwide demand and manufacturing capacity
utilization for semiconductors (the principal product of our customer
base), competitive products and pricing, manufacturing efficiencies, new
product development and customer acceptance of new products, ability to
enforce patents and protect intellectual property rights, the outcome of
intellectual property litigation, availability of raw materials and
critical manufacturing equipment, trade environment, changes in exchange
rates and other risks indicated in the risk factors included in ASML’s
Annual Report on Form 20-F and other filings with the US Securities and
Exchange Commission.
1 All quarterly information in this press
release is unaudited.
2 The calculation of diluted net income per
ordinary share assumes conversion of our Subordinated Notes as such
conversions would have a dilutive effect.
3 The calculation of diluted net income per
ordinary share assumes the exercise of options issued under ASML stock
option plans as such exercises would have a dilutive effect.
4 As of January 1, 2008 ASML accounts for
award credits offered to its customers as part of a volume purchase
agreement using the deferred revenue model. Until December 31, 2007 the
cost accrual method was used. This change in accounting policy was made
because the deferred revenue model better reflects the business
rationale. In addition the International Financial Reporting
Interpretation Committee concludes in interpretation 13 (IFRIC 13 "Customer
Loyalty Programmes”) that the deferred
revenue model is the appropriate accounting treatment. Comparative
figures for 2007 were adjusted to reflect this change in accounting
policy. The impact of this change on equity as per January 1, 2007
amounted to EUR 8.1 million (decrease) and on net income for the year
2007 and the first quarter of 2008 amounted to EUR 8.6 million
(decrease) and EUR 0.1 million (increase) respectively.